$44.16 $0.49 per serving
Product analysis
Complete Omega Lemon combines omega fats that contribute to normal skin lipids. Unresolved component details make it difficult to judge whether the oil matches preparations associated with specific skin effects.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality20
The ingredient disclosure omits the forms of the omega fats. Their quality cannot be compared confidently from those details alone.
Ingredient Transparency63
Amounts are listed for the broad omega categories, but their forms are omitted. Those totals do not resolve the individual fatty-acid breakdown.
Value For Money63
Omega-6 and omega-9 have favorable cost comparisons, while omega-3 offers middling value. The fatty-acid breakdown matters when comparing the usefulness of the complete oil.
Customer Satisfaction86
Customer feedback is very positive. A sizeable set of reviews supports that impression, without proving effectiveness or safety.
Product Focus71
Omega-3 fats have a role in normal skin lipids. Skin findings from a specific high-dose purified preparation do not establish the same benefit from this mixed oil.
- Format
Softgel - Container
- 180 Softgel(s)
- Per serving
- $0.49
- Also available
Complete Omega Jr. Lemon$31.41- Customer rating
- 4.8 · 1,529 ratings
Goals
Impact
High effect
Omega-3 · 565 mg
Omega-3 fatty acids have a connection to skin lipid function, but the supplied human UV findings used a specific high-dose purified EPA preparation. Those findings cannot establish routine skin benefits from a generic omega-3 amount. The declared total remains separate from unresolved component declarations. The claimed GLA amount remains unresolved in the imported ingredient facts.
How this product is rated for Skin Health
Ingredient fit83
The relevant ingredient is the main active focus, though the product may serve several goals. The omega-3 serving receives partial amount recognition; it does not establish a preparation-specific skin study exposure.
Goal fit
The relevant ingredient is the main active focus, though the product may serve several goals.
Dose adequacy
The omega-3 serving receives partial amount recognition; it does not establish a preparation-specific skin study exposure.
Pathways17
The saved findings assign omega-3 to barrier lipids; the supplied scientific context does not confirm a generic omega-3 skin benefit.
Depth
The saved findings assign omega-3 to barrier lipids; the supplied scientific context does not confirm a generic omega-3 skin benefit.
Breadth
No skin outcome pathway reaches the saved coverage threshold.
Evidence78
Omega-3 receives evidence recognition in the saved findings, but the supplied trials do not establish a transferable dose for generic omega-3.
Evidence strength
Omega-3 receives evidence recognition in the saved findings, but the supplied trials do not establish a transferable dose for generic omega-3.
Studied preparation
The saved findings recognize the preparation, but generic omega-3 cannot be equated with the purified EPA used in the supplied human trial.
Formulation logic100
The credited ingredients have no unmet partner requirement or matched conflict in the saved findings. Their amounts pass the saved minimum inclusion check.
Partner coverage
The credited ingredients are treated as able to contribute independently or as having their required partner.
Conflicts
No configured ingredient conflict was matched in the supplied findings.
Effective doses
The credited ingredient amounts pass the saved minimum inclusion check; this is not a proven effective skin dose.
Omega-9 Not classified
No linked studies yet.
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Calories | 20 Calorie(s) | |
Total Fat | 2 Gram(s) | |
Total Omega-3 Fatty Acids | 565 mg | |
Omega-6 Fatty Acids | 240 mg | |
Omega-9 Fatty Acids | 225 mg |
Omega-9 · 225 mg OverallScore76
Omega-6 · 240 mg OverallScore76
A serving provides 240 mg of omega-6, including 70 mg of gamma-linolenic acid (GLA). The remaining omega-6 and the specific oil source are not identified in the saved facts.
How this ingredient is rated
Active Ingredient Quality & Bioavailability64
GLA is identified at 70 mg per serving, but the saved facts do not name its oil source or identify the remaining omega-6. No extraction method is recorded in the saved facts.
Omega-6 Source & GLA Content
GLA is identified at 70 mg per serving, but the saved facts do not name its oil source or identify the remaining omega-6.
Extraction Method & Purity
No extraction method is recorded in the saved facts.
Dose, Safety & Label Transparency85
A serving contains 240 mg omega-6, including 70 mg of GLA; the remaining fatty acids are not identified in the saved facts.
Omega-6 Potency vs. Median
A serving contains 240 mg of omega-6.
Fatty Acid Profile Transparency
GLA is listed at 70 mg per serving; the rest of the omega-6 is not broken down in the saved facts.
Value80
A whole-product serving costs about $0.49.
Price Per Serving Efficiency
A whole-product serving costs about $0.49.
Omega-3 · 565 mg OverallScore74
Alternative products
Report alternatives
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Dietetic intervention in psoriatic arthritis: the DIETA trial.
- Omega-3 fatty acid supplement skin cancer prophylaxis in lung transplant recipients: A randomized, controlled pilot trial.
- Clinical and metabolic response to flaxseed oil omega-3 fatty acids supplementation in patients with diabetic foot ulcer: A randomized, double-blind, placebo-controlled trial.
- Treatment of hard-to-heal wounds in ischaemic lower extremities with a novel fish skin-derived matrix.
- Effect of eicosapentaenoic acid, an omega-3 polyunsaturated fatty acid, on UVR-related cancer risk in humans. An assessment of early genotoxic markers.
- Psychosocial Burden in People with Atopic Dermatitis: Effects of a Substance-Free Basic Skincare in a Randomized Health Care Study.
- Abnormalities in epidermal lipid metabolism in patients with atopic dermatitis.
- Maternal plasma phosphatidylcholine fatty acids and atopy and wheeze in the offspring at age of 6 years.
- Plasma omega-3 and omega-6 concentrations and risk of cutaneous basal and squamous cell carcinomas in Australian adults.
- Maternal PUFA status and offspring allergic diseases up to the age of 18 months.